A small-scale experiment of using phage-based probiotic dietary supplement for prevention of E. coli traveler's diarrhea

Aleshkin, A. V.; Rubalskii, Evgenii; Volozhantsev, Nikolay V.; Verevkin, Vladimir V.; Svetoch, E. A.; Киселева, И. А.; Bochkareva, S.S.; Borisova, O. Yu.; Popova, Anastasiya V.; Богун, А. Г.; Афанасьев, С. С.

doi:10.1080/21597081.2015.1074329

Cited by 17 publications

(13 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Phylogenetic analysis of phage RB49 revealed a distance from T4 and justified a classification as a pseudo-T-even phage [67]. Some members of this genus ( Krischvirus ) have also been described in literature dealing with different topics [68,69,70,71]; they have a slightly smaller genome size (~164 kb) than T4-likes, carry no tRNAs, and their DNA contains cytosine and no 5-hydroxymethylcytosine. In comparison, RB69-like phages are much more closely related to T4 at the nucleotide level than krischviruses; most of the members, such as RB69 or PhaPEC2 [72,73], have a genome size of about 168 kb, similar to T4, and reveal two or three tRNAs while tequatroviruses of our study displayed up to 12 tRNAs.…”

Section: Resultsmentioning

confidence: 99%

Still Something to Discover: Novel Insights into Escherichia coli Phage Diversity and Taxonomy

Korf

Meier‐Kolthoff

Adriaenssens

et al. 2019

Viruses

View full text Add to dashboard Cite

The aim of this study was to gain further insight into the diversity of Escherichia coli phages followed by enhanced work on taxonomic issues in that field. Therefore, we present the genomic characterization and taxonomic classification of 50 bacteriophages against E. coli isolated from various sources, such as manure or sewage. All phages were examined for their host range on a set of different E. coli strains, originating, e.g., from human diagnostic laboratories or poultry farms. Transmission electron microscopy revealed a diversity of morphotypes (70% Myo-, 22% Sipho-, and 8% Podoviruses), and genome sequencing resulted in genomes sizes from ~44 to ~370 kb. Annotation and comparison with databases showed similarities in particular to T4- and T5-like phages, but also to less-known groups. Though various phages against E. coli are already described in literature and databases, we still isolated phages that showed no or only few similarities to other phages, namely phages Goslar, PTXU04, and KWBSE43-6. Genome-based phylogeny and classification of the newly isolated phages using VICTOR resulted in the proposal of new genera and led to an enhanced taxonomic classification of E. coli phages.

show abstract

Section: Resultsmentioning

confidence: 99%

Still Something to Discover: Novel Insights into Escherichia coli Phage Diversity and Taxonomy

Korf

Meier‐Kolthoff

Adriaenssens

et al. 2019

Viruses

View full text Add to dashboard Cite

show abstract

“…Phage JES-2013 is lytic against Lactococcus lactis [ 54 ]. The putative tail fibre sequences from PDX had a 99 % amino acid identity with Myoviridae Escherichia phage V18 [ 55 ]. Overall, the phage that had the highest percentage identity scores with the PDX genome sequence and tail fibre amino acid sequence were all strictly lytic Myoviridae against various E. coli strains.…”

Section: Resultsmentioning

confidence: 99%

“…For example, the Myoviridae phage Murica (Table S2) is being researched as a potential treatment for contaminated food products [ 52 ]. Escherichia phage V18 was part of a successful prophylactic phage cocktail used in the prevention of traveller’s diarrhoea in mice infected with six bacterial strains, including E. coli, Shigella flexneri , Shigella sonnei , Salmonella enetica , Listeria monocytogenes or Staphylococcus aureus , and Lac (−) E. coli K-12 C600 [ 55 ]. Similar to PDX replicating in clinical isolates of both EAEC and EPEC pathotypes, the related V18 phage was cited as having a host range that included ETEC, EAEC and enterohaemorrhagic E. coli (EHEC).…”

Section: Discussionmentioning

confidence: 99%

Myoviridae phage PDX kills enteroaggregative Escherichia coli without human microbiome dysbiosis

Cepko

Garling

Dinsdale

et al. 2020

Journal of Medical Microbiology

View full text Add to dashboard Cite

Introduction Bacteriophage therapy can be developed to target emerging diarrhoeal pathogens, but doing so in the absence of microbiome disruption, which occurs with antibiotic treatment, has not been established. Aim Identify a therapeutic bacteriophage that kills diarrhoeagenic enteroaggregative Escherichia coli (EAEC) while leaving the human microbiome intact. Methodology Phages from wastewater in Portland, OR, USA were screened for bacteriolytic activity by overlay assay. One isolated phage, PDX , was classified by electron microscopy and genome sequencing. A mouse model of infection determined whether the phage was therapeutic against EAEC. 16S metagenomic analysis of anaerobic cultures determined whether a normal human microbiome was altered by treatment. Results Escherichia virus PDX , a member of the strictly lytic family Myoviridae , killed a case-associated EAEC isolate from a child in rural Tennessee in a dose-dependent manner, and killed EAEC isolates from Columbian children. A single dose of PDX (multiplicity of infection: 100) 1 day post-infection reduced EAEC recovered from mouse faeces. PDX also killed EAEC when cultured anaerobically in the presence of human faecal bacteria. While the addition of EAEC reduced the β-diversity of the human microbiota, that of the cultures with either faeces alone, faeces with EAEC and PDX , or with just PDX phage was not different statistically. Conclusion PDX killed EAEC isolate EN1E-0007 in vivo and in vitro , while not altering the diversity of normal human microbiota in anaerobic culture, and thus could be part of an effective therapy for children in developing countries and those suffering from EAEC-mediated traveller’s diarrhoea without causing dysbiosis.

show abstract

“…The putative tail fiber sequences from PDX had a 99% amino acid identity with Myoviridae Escherichia phage V18 (55). Overall, the phage that had the highest percent identity scores with the PDX genome sequence and tail fiber amino acid sequence were all strictly lytic Myoviridae against various E. coli strains.…”

Section: Resultsmentioning

confidence: 98%

MyoviridaePhagePDXKills EnteroaggregativeEscherichia coliwithout Human Microbiome Dysbiosis

Cepko

Garling

Dinsdale

et al. 2018

Preprint

View full text Add to dashboard Cite

Escherichia virus, microbiome, dysbiosis antibiotic alternatives. AbstractPurpose. To identify therapeutic a bacteriophage that kills diarrheagenic enteroaggregative Escherichia coli (EAEC) while leaving the human microbiome intact.Methodology. Phages from wastewater in Portland, OR, were screened for bacteriolytic activity using an overlay assay, and isolated in a sequential procedure to enrich for the recognition of core bacterial antigens. Electron microscopy and genome sequencing were performed to classify the isolated phage, and the host range was determined by spot tests and plaque assays. One-step growth curves and time-kill assays were conducted to characterize the life cycle of the phage, and to interrogate the multiplicity of infection (MOI) necessary for killing. A mouse model of infection was used to determine whether the phage could be used therapeutically against EAEC in vivo. Anaerobic culture in the presence of human fecal bacteria determined whether the phage could kill EAEC in vitro, and to assess whether the microbiome had been altered.Results. The isolated phage, termed Escherichia virus PDX, is a member of the strictly lytic Myoviridae family of viruses. Phage PDX killed EAEC isolate EN1E-0227, a case-associated isolate from a child in rural Tennessee, in a dose-dependent manner, and also formed plaques on case-associated clinical EAEC isolates from Columbian children suffering from diarrhea. A single dose of PDX, at a MOI of 100, one day post infection, reduced the population of recovered EAEC isolate EN1E-0227 bacteria in fecal pellets in a mouse model of colonization, over a fiveday period. Phage PDX also killed EAEC EN1E-0227 when cultured anaerobically in vitro in the presence of human fecal bacteria. While the addition of EAEC EN1E-0227 reduced the adiversity of the human microbiota, that of the cultures with either feces alone, feces with EAEC and PDX, or with just the PDX phage were not different statistically, as measured by Chao1 and Shannon diversity indices. Additionally, b-diversity and differential abundance analyses show that conditions with PDX added were not different from feces alone, but all groups were significantly different from feces + EAEC.Conclusions. The strictly bacteriolytic, Myoviridae Escherichia virus PDX killed EAEC isolate EN1E-0227 bacteria both in vivo and in vitro, while simultaneously not altering the diversity of normal human microbiota in anaerobic culture. Thus, the PDX phage could be part of an effective therapeutic intervention for children in developing countries who suffer from acute, or persistent EAEC-mediated diarrhea, and to help reduce the serious effects of environmental enteropathy. Because the emerging pathogen EAEC is now the second leading cause of traveler's diarrhea, PDX could also provide therapeutic relief for these individuals, particularly in light of the growing crisis of antibiotic resistances.

show abstract

A small-scale experiment of using phage-based probiotic dietary supplement for prevention of E. coli traveler's diarrhea

Cited by 17 publications

References 6 publications

Still Something to Discover: Novel Insights into Escherichia coli Phage Diversity and Taxonomy

Still Something to Discover: Novel Insights into Escherichia coli Phage Diversity and Taxonomy

Myoviridae phage PDX kills enteroaggregative Escherichia coli without human microbiome dysbiosis

MyoviridaePhagePDXKills EnteroaggregativeEscherichia coliwithout Human Microbiome Dysbiosis

Contact Info

Product

Resources

About